| 货号 | 规格 | 价格 | 上海 | 北京 | 武汉 | 南京 | 购买数量 |
|---|---|---|---|---|---|---|---|
| S80140-1mg | ≥98% | ￥135.00 | 10 | - | - | - |
|
| S80140-5mg | ≥98% | ￥343.00 | 10 | - | - | - |
|
| S80140-10mg | ≥98% | ￥607.00 | 10 | - | - | - |
|
| S80140-25mg | ≥98% | ￥867.00 | 9 | - | - | - |
|
| S80140-50mg | ≥98% | ￥1519.00 | 1 | - | - | - |
|
BMS-794833 is a VEGFR2 and Met inhibitor extracted from patent WO2009094417, compound example 1; has IC50s of 15 and 1.7 nM, respectively.
| 产品描述： | BMS-794833 is a VEGFR2 and Met inhibitor extracted from patent WO2009094417, compound example 1; has IC50s of 15 and 1.7 nM, respectively. | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶点： | VEGFR2:15 nM (IC50);Met:1.7 nM (IC50);VEGFR;c-Met/HGFR | ||||||||||||||||||||
| 体内研究： | BMS-794833 is active by greater than 50% tumor growth inhibition for at least one tumor doubling time in the GTL-16 gastric carcinoma model. No toxicity is observed at any of the dose levels when administered once daily for a duration of 14 days | ||||||||||||||||||||
| 参考文献： | 1. WO2009094417 | ||||||||||||||||||||
| 溶解性： | Soluble in DMSO | ||||||||||||||||||||
| 保存条件： | -20℃ | ||||||||||||||||||||
| 配置溶液浓度参考： |
|
||||||||||||||||||||
| 注意： | 部分产品我司仅能提供部分信息，我司不保证所提供信息的权威性，仅供客户参考交流研究之用。 |
上海工商
沪公网安备 31011702002021号
危险品化学品经营许可证（不带存储）
营业执照(三证合一)
北京